Science

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Rating Reaffirmed by Cann

Equities research analysts forecast that Editas Medicine will post ($3.04) earnings per share for the current fiscal year.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 6, and a price to sales ratio of 4.88.

Editas Medicine, Inc. (EDIT) failed to surprise the stock market in its last reported earnings when it earned -$0.85 a piece versus the consensus-estimated -$0.61. The company reported ($0.65) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.64) by $0.01. The company had revenue of $3.10 million for the quarter, compared to the consensus estimate of $2.20 million. The return on equity ratio or ROE stands at -63.3 percent while most common profitability ratio return on investment (ROI) was -54.1 percent. The firm's quarterly revenue was down 8.8% compared to the same quarter a year ago. Next quarter's EPS is estimated at $-0.71 and the next full year EPS is anticipated to be $-3.18.

COPYRIGHT VIOLATION NOTICE: "Editas Medicine, Inc. (NASDAQ:EDIT) Expected to Announce Quarterly Sales of $2.88 Million" was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another website, it was stolen and reposted in violation of USA & worldwide copyright and trademark law. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/08/10/editas-medicine-inc-nasdaqedit-given-a-27-00-price-target-by-j-p-morgan-chase-co-analysts.html.

Several other equities analysts have also recently commented on the stock. Zacks Investment Research cut Editas Medicine from a "buy" rating to a "hold" rating in a report on Tuesday, July 18th. They issued a "buy" rating on the stock. SunTrust Banks, Inc. assumed coverage on Editas Medicine in a research note on Thursday, July 13th. The longer the bull market run, the tougher the investing decisions might be for the stock picker. The RSI was created by J. Welles Wilder who was striving to measure whether or not a stock was overbought or oversold. The company presently has a consensus rating of Buy and an average target price of $25.03.

Editas Medicine (EDIT) opened at 17.98 on Wednesday. The company's market capitalization is $644.33 million. This indicator compares the closing price of a stock in relation to the highs and lows over a certain time period. The firm's 50 day moving average is $16.99 and its 200 day moving average is $18.99. State Street Corp increased its position in shares of Editas Medicine by 2.4% in the fourth quarter. TD Asset Management Inc. now owns 33,770 shares of the company's stock valued at $754,000 after buying an additional 2,800 shares during the period. Creative Planning boosted its stake in Editas Medicine by 8,910.9% in the second quarter. Schwab Charles Investment Management Inc. increased its position in shares of Editas Medicine by 8.4% in the first quarter. Also, Director Kevin Bitterman sold 1,000,000 shares of Editas Medicine stock in a transaction dated Monday, May 22nd. A reading under 30 may indicate that the stock is oversold, and possibly undervalued. The transaction was disclosed in a document filed with the SEC, which is available through this link.

In other news, Director Boris Nikolic bought 35,000 shares of the business's stock in a transaction that occurred on Friday, June 2nd. The shares were bought at an average cost of $14.15 per share, for a total transaction of $56,600.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions.

Editas Medicine, Inc. engages in the development and commercialization of genome editting technology. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. The Company operates through developing and commercializing genome editing technology segment.



Like this

Latest


11 August 2017
Fiesta Restaurant Group, Inc. (FRGI) moved with flow of 9.79% on Tuesday
Guggenheim Capital LLC purchased a new stake in shares of Fiesta Restaurant Group during the fourth quarter valued at $225,000. For the past 5 years, the company's revenue has grown -2.8%, while the company's earnings per share has grown -0.7%.

11 August 2017
Tanya Tucker releases 'Forever Loving You' in memory of Glen Campbell
After a long battle with Alzheimer's disease , Glen Campbell passed away on Tuesday, August 8th in Tennessee. His last performance was in California in November 2012 where three of his children accompanied him.

11 August 2017
NYPD Officer Shot in Cypress Hills, Officials Say
The shooting happened near Ridgewood Avenue and Essex Street at about 4:35 p.m., according to FDNY and NYPD officials. A police officer was shot in Brooklyn by a man believed to be emotionally disturbed, an NYPD spokeswoman said.

11 August 2017
Trump Says Working With Mueller on Russia Probe, Denies Any Election Collusion
In the 2016 presidential election, then-candidate Trump received approximately 4 percent of the vote in the nation's capital. Trump has long derided Mueller's probe, calling it a " witch hunt " and suggesting his team is "biased".

11 August 2017
Rockets re-engage Knicks on Carmelo Anthony
The Knicks attempted to convince Anthony to stay in NY after the hiring of Perry, but they were reportedly unsuccessful.

11 August 2017
Almost seven in 10 judge Congress a failure so far
Republicans themselves are evenly split 44% to 44% on whether the GOP-led Congress has been a success or failure so far. Since the legislative failure, Trump has been hammering away at Senate leadership to come up with another plan.

11 August 2017
Regentatlantic Capital LLC Has $812000 Position in NVIDIA Corporation (NASDAQ:NVDA)
On average, equities research analysts anticipate that NVIDIA Corporation will post $3.10 EPS for the current fiscal year. Also, Director Persis Drell sold 2,500 shares of the firm's stock in a transaction that occurred on Thursday, May 18th.

11 August 2017
Nordstrom, Inc. (NYSE:JWN) Updates FY18 Earnings Guidance
Maxim Group set a $61.00 price objective on Nordstrom and gave the stock a "buy" rating in a report on Thursday, May 4th. Moreover, Princeton Capital Management Inc has 0.06% invested in the company for 40,170 shares. (NYSE:JWN).

11 August 2017
Harley-Davidson inks jersey deal with Bucks
This is how the Bucks' home uniform will look with the Harley-Davidson advertising patch. Jerseys purchased at at the Bucks shop will feature the Harley-Davidson logo.

11 August 2017
Halle Berry has a mind-blowing secret about X-Men's Storm and Wolverine
Fans had often wondered what it all meant but nobody has spoken up about it until now. The actress just revealed who has been putting the X into sex at the X-Men mansion.



Recommended